Evaluating medicines: Let's use all the evidence

Chris W. Kelman, Sallie Anne Pearson, Richard O. Day, C. D.Arcy J. Holman, Erich V. Kliewer, David A. Henry

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

Summary
• The current drug regulatory system is outdated and relies primarily on a process of premarketing evaluation, followed by periodic reviews of reported adverse events.
• While long-term medicine use for chronic conditions is now commonplace, current drug evaluation systems do not incorporate the comprehensive evidence accruing over time in clinical practice. Good quality, routinely collected data on medicines use are now available in some countries.
• Consistent with international opinion, we propose an expanded and integrated system of medicines regulation for Australia, based on a surveillance system that improves safety monitoring by complementing existing systems, making best use of routinely collected data, and leveraging the power of information technology.
• Australia is well placed to pilot such a model system.
Original languageEnglish
Pages (from-to)249-252
Number of pages4
JournalMedical Journal of Australia
Volume186
Issue number5
Publication statusPublished - 5 Mar 2007
Externally publishedYes

Fingerprint

Drug Evaluation
Systems Analysis
Medicine
Technology
Safety
Pharmaceutical Preparations

Cite this

Kelman, C. W., Pearson, S. A., Day, R. O., Holman, C. D. A. J., Kliewer, E. V., & Henry, D. A. (2007). Evaluating medicines: Let's use all the evidence. Medical Journal of Australia, 186(5), 249-252.
Kelman, Chris W. ; Pearson, Sallie Anne ; Day, Richard O. ; Holman, C. D.Arcy J. ; Kliewer, Erich V. ; Henry, David A. / Evaluating medicines : Let's use all the evidence. In: Medical Journal of Australia. 2007 ; Vol. 186, No. 5. pp. 249-252.
@article{e45c6b71e4724b228cd5b4a20701f6ef,
title = "Evaluating medicines: Let's use all the evidence",
abstract = "Summary• The current drug regulatory system is outdated and relies primarily on a process of premarketing evaluation, followed by periodic reviews of reported adverse events. • While long-term medicine use for chronic conditions is now commonplace, current drug evaluation systems do not incorporate the comprehensive evidence accruing over time in clinical practice. Good quality, routinely collected data on medicines use are now available in some countries. • Consistent with international opinion, we propose an expanded and integrated system of medicines regulation for Australia, based on a surveillance system that improves safety monitoring by complementing existing systems, making best use of routinely collected data, and leveraging the power of information technology. • Australia is well placed to pilot such a model system.",
author = "Kelman, {Chris W.} and Pearson, {Sallie Anne} and Day, {Richard O.} and Holman, {C. D.Arcy J.} and Kliewer, {Erich V.} and Henry, {David A.}",
year = "2007",
month = "3",
day = "5",
language = "English",
volume = "186",
pages = "249--252",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AUSTRALASIAN MED PUBL CO LTD",
number = "5",

}

Kelman, CW, Pearson, SA, Day, RO, Holman, CDAJ, Kliewer, EV & Henry, DA 2007, 'Evaluating medicines: Let's use all the evidence' Medical Journal of Australia, vol. 186, no. 5, pp. 249-252.

Evaluating medicines : Let's use all the evidence. / Kelman, Chris W.; Pearson, Sallie Anne; Day, Richard O.; Holman, C. D.Arcy J.; Kliewer, Erich V.; Henry, David A.

In: Medical Journal of Australia, Vol. 186, No. 5, 05.03.2007, p. 249-252.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Evaluating medicines

T2 - Let's use all the evidence

AU - Kelman, Chris W.

AU - Pearson, Sallie Anne

AU - Day, Richard O.

AU - Holman, C. D.Arcy J.

AU - Kliewer, Erich V.

AU - Henry, David A.

PY - 2007/3/5

Y1 - 2007/3/5

N2 - Summary• The current drug regulatory system is outdated and relies primarily on a process of premarketing evaluation, followed by periodic reviews of reported adverse events. • While long-term medicine use for chronic conditions is now commonplace, current drug evaluation systems do not incorporate the comprehensive evidence accruing over time in clinical practice. Good quality, routinely collected data on medicines use are now available in some countries. • Consistent with international opinion, we propose an expanded and integrated system of medicines regulation for Australia, based on a surveillance system that improves safety monitoring by complementing existing systems, making best use of routinely collected data, and leveraging the power of information technology. • Australia is well placed to pilot such a model system.

AB - Summary• The current drug regulatory system is outdated and relies primarily on a process of premarketing evaluation, followed by periodic reviews of reported adverse events. • While long-term medicine use for chronic conditions is now commonplace, current drug evaluation systems do not incorporate the comprehensive evidence accruing over time in clinical practice. Good quality, routinely collected data on medicines use are now available in some countries. • Consistent with international opinion, we propose an expanded and integrated system of medicines regulation for Australia, based on a surveillance system that improves safety monitoring by complementing existing systems, making best use of routinely collected data, and leveraging the power of information technology. • Australia is well placed to pilot such a model system.

UR - http://www.scopus.com/inward/record.url?scp=33947209116&partnerID=8YFLogxK

M3 - Article

VL - 186

SP - 249

EP - 252

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 5

ER -

Kelman CW, Pearson SA, Day RO, Holman CDAJ, Kliewer EV, Henry DA. Evaluating medicines: Let's use all the evidence. Medical Journal of Australia. 2007 Mar 5;186(5):249-252.